Eli Lilly nears $2 bln deal for cancer biotech Kelonia, WSJ reports

Investing.com Gold reports: Eli Lilly nears $2 bln deal for cancer biotech Kelonia, WSJ reports. Full body text was unavailable at ingest time, so this brief is based on headline context.